Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins

Brain Research

Volumn 707, Issue 2, 1996, Pages 235-244

  Ammer, Hermann ^a   Schulz, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenylate cyclase supersensitivity; Morphine; Opiate tolerance and dependence; PGE1 receptor; SH SY5Y cell; Stimulatory G protein; Stimulatory signal transduction; Opioid receptor

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN; FORSKOLIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; MORPHINE; NALOXONE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MORPHINE ADDICTION; NEUROBLASTOMA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030020029     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01265-6     Document Type: Article

References (37)

1. S) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists, Biochem. J., 285 (1992) 529-536.
2. S-adenylate cyclase interactions, FASEB J., 5 (1991) 2300-2303.
3. s is enhanced in neuroblastoma X glioma (NG108-15) hybrid cells chronically exposed to an opioid, Mol. Pharmacol., 43 (1993) 556-563.
4. Ammer, H. and Schulz, R., Retinoic acid-induced differentiation of human neuroblastoma SH-SY5Y cells is associated with changes in the abundance of G proteins, J. Neurochem., 62 (1994) 1310-1318.
5. αs and opioid peptide mRNA levels in discrete brain regions, J. Neurosci. Res., 36 (1993) 551-557.
6. Birnbaumer, L., Abramowitz, J. and Brown, A.M., Receptor-effector coupling by G proteins, Biochim. Biophys. Acta, 1031 (1990) 163-224.
7. Carter, B.D. and Medzihradsky, F., Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells, Mol. Pharmacol., 43 (1993) 465-473.
8. Collier, H.O.J., Cellular aspects of opioid tolerance and dependence. In J. Hughes, H.O.J. Collier, M.J. Rance and M.B. Tyres (Eds.), Opioids: Past, Present and Future, Taylor and Francis Ltd., London, 1984, pp. 109-125.
9. s α activity and abundance, Biochem. J., 288 (1992) 331-336.
10. Frandsen, E.K. and Krishna, G., A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues, Life Sci., 18 (1977) 529-542.
11. 32P]ADP-ribosylation of proteins, Methods Enzymol., 195 (1991) 267-280.
12. 2-adrenergic, muscarinergic, and opiate receptors, Mol. Pharmacol., 43 (1993) 434-443.
13. Guitard, X., Thompson, M.A., Mirante, C.K., Greenberg, M.E. and Nestler, E.J., Regulation of CREB phosphorylation by acute and chronic morphine in the rat locus coeruleus, J. Neurochem., 58 (1992) 1168-1171.
14. 2-adrenergic receptors, J. Biol. Chem., 266 (1991) 11915-11922.
15. s protein and β-adrenergic receptors by a physiological stimulus, chronic dynamic exercise, J. Clin. Invest., 82 (1988) 2168-2171.
16. Hausdorff, W.P., Caron, M.G. and Lefkowitz, R.J., Turning off the signal: desensitization of β-adrenergic receptor function, FASEB J., 4 (1990) 2881-2889.
17. Johnson, S.M. and Fleming, W.W., Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence, Pharmacol. Rev., 41 (1989) 435-488.
18. Laemmli, U.K., Cleavage of structural proteins during the assembly of the head bacteriophage T4, Nature, 227 (1970) 680-685.
19. Law, P.Y., Hom, D.S. and Loh, H.H., Loss of opiate receptor activity in neuroblastoma x glioma NG108-15 hybrid cells after chronic opiate treatment, Mol. Pharmacol., 22 (1982) 1-4.
20. Law, P.Y., Horn, D.S. and Loh, H.H., Opiate receptor down-regulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two separate cellular adaptation processes, Mol. Pharmacol., 24 (1983) 413-424.
21. Law, P.Y., Horn, D.S. and Loh, H.H., Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells: chloroquine promotes accumulation of tritiated enkephalin in the lysosomes, J. Biol. Chem., 259 (1984) 4096-4104.
22. i α are not associated with changes in their mRNAs, Mol. Pharmacol., 36 (1989) 681-688.
23. May, D.C., Ross, E.M., Oilman, A.G. and Smigel, M.D., Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins, J. Biol. Chem., 260 (1985) 15829-15833.
24. 1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells, Mol. Pharmacol., 22 (1982) 360-368.
25. Nestler, E.J., Molecular mechanisms of drug addiction, J. Neurosci., 12 (1992) 2439-2450.
26. Nestler, E.J. and Tallman, J.F., Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus, Mol. Pharmacol., 33 (1988) 127-132.
27. Neubig, R.R., Membrane organization in G-protein mechanisms, FASEB J., 8 (1994) 939-946.
28. Påhlman, S., Ruusala, A.I., Abrahamsson, L., Mattsson, M.E.K. and Esschner, T., Retinoic acid-induced differentiation of cultured human neuroblastoma cells: comparison with phorbolester-induced differentiation, Cell. Differ., 14 (1984) 135-144.
29. Peterson, G.L., Determination of total protein, Methods Enzymol., 91 (1983) 95-119.
30. Sharma, S.K., Klee, W.A. and Nirenberg, M., Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance, Proc. Natl. Acad. Sci. USA, 72 (1975) 3092-3096.
31. Scatchard, G., The attractions of proteins for small molecules and ions, Ann. NY Acad. Sci., 51 (1949) 660-672.
32. s carboxyl-terminal decapeptide, FEBS Lett., 249 (1989) 189-194.
33. Thomas, J.M. and Hoffman, B.B., Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists?, Trends Pharmacol. Sci., 8 (1987) 308-311.
34. i-proteins underlie adenylyl cyclase sensitization in morphinetreated rat striatal neurons, Eur. J. Pharmacol. Mol. Pharmacol., 245 (1993) 23-29.
35. Wüster, M., Schulz, R. and Herz, A., Opiate tolerance and dependence: re-evaluating the unitary hypothesis, Trends Pharmacol. Sci., 6 (1985) 64-67.
36. Yu, V.C., Eiger, S., Duan, D.-S., Lameh, J. and Sadée, W., Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells, J. Neurochem., 55 (1990) 1390-1396.
37. Yu, V.C. and Sadée, W., Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells, J. Pharmacol. Exp. Ther., 245 (1988) 350-355.